Ryne Biotechnology Funding & Investors

Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States.

Total Amount Raised: $89,000,000

Ryne Biotechnology Funding Rounds

Series A
$82,000,000
Feb 28, 2024
Series A Investors
Alaska Permanent Fund
Cure Ventures
Column Group
Euclidean Capital
Saisei Ventures
Grant
$4,000,000
Feb 13, 2023
Grant Investors
California Institute for Regenerative Medicine
Seed
$3,000,000
Jul 19, 2022
Seed Investors
Saisei Ventures

Funding info provided by Diffbot.